MedPath

A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Registration Number
NCT01007409
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
Brief Summary

To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
24
Inclusion Criteria
  • age: 20 - 45 years
  • sex: male
  • body weight: greater than 55 kg
  • written informed consent
Read More
Exclusion Criteria
  • known allergy to Fimasartan
  • existing cardiac or hematological diseases
  • existing hepatic and renal diseases
  • existing gastrointestinal diseases
  • acute or chronic diseases which could affect drug absorption or metabolism history of any serious psychological disorder
  • abnormal diet which could affect drug absorption or metabolism
  • positive drug or alcohol screening
  • smokers of 10 or more cigarettes per day
  • participation in a clinical trial during the last 60 days prior to the start of the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Group AFimasartanPeriod 1: fasted control → Period 2: fed control
Group BFimasartanPeriod 1: fed control → Period 2: fasted control
Primary Outcome Measures
NameTimeMethod
Cmax, Tmax, AUC, T1/2, CL/F etc.0, 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24 hours
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath